Theriva Biologics SG&A Expense (TTM) Trends

Theriva Biologics Inc (TOVX)

0.2363 -0.01 (-2.80%) USD | NYAM | Jun 28, 16:00

0.234 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1993. Upgrade now.

Date	Value
March 31, 2024	6.853M
December 31, 2023	7.121M
September 30, 2023	9.346M
June 30, 2023	11.55M
March 31, 2023	10.40M
December 31, 2022	9.858M
September 30, 2022	8.098M
June 30, 2022	6.985M
March 31, 2022	6.709M
December 31, 2021	6.473M
September 30, 2021	5.14M
June 30, 2021	5.034M
March 31, 2021	5.055M
December 31, 2020	5.029M
September 30, 2020	5.159M
June 30, 2020	5.06M
March 31, 2020	4.818M
December 31, 2019	4.579M
September 30, 2019	4.498M
June 30, 2019	4.874M
March 31, 2019	5.261M
December 31, 2018	5.727M
September 30, 2018	6.552M
June 30, 2018	6.783M
March 31, 2018	6.996M

Date	Value
December 31, 2017	7.466M
September 30, 2017	8.914M
June 30, 2017	9.304M
March 31, 2017	9.807M
December 31, 2016	10.14M
September 30, 2016	9.203M
June 30, 2016	8.712M
March 31, 2016	8.787M
December 31, 2015	8.074M
September 30, 2015	7.398M
June 30, 2015	7.012M
March 31, 2015	6.604M
December 31, 2014	6.013M
September 30, 2014	5.716M
June 30, 2014	6.388M
March 31, 2014	5.832M
December 31, 2013	5.832M
September 30, 2013	5.565M
June 30, 2013	4.748M
March 31, 2013	4.666M
December 31, 2012	5.012M
September 30, 2012	3.966M
June 30, 2012	3.475M
March 31, 2012	2.823M
December 31, 2011	2.588M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.498M

Minimum

Sep 2019

11.55M

Maximum

Jun 2023

6.725M

Average

6.473M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks